BioSpace News Archive

BioMidwest

Kraig Biocraft Laboratories Collaboration Between US and Vietnam Teams Completes First 100% Genetic Screening for In-Process Spider Silk Production

Kraig Biocraft Laboratories, Inc., the biotechnology company focused on the development and commercialization of spider silk, announced significant advancements in its Vietnam based production facility, Prodigy Textiles.

March 7, 2022
·
2 min read
Business

EyePoint Pharmaceuticals Appoints Isabelle Lefebvre as Chief Regulatory Officer

EyePoint Pharmaceuticals, Inc. today announced the appointment of Isabelle Lefebvre as Chief Regulatory Officer.

March 7, 2022
·
5 min read
Drug Development

VYNE Reports Positive Preclinical Data for Lead BET Inhibitor, VYN201, in Human Skin Model of Vitiligo

VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a biopharmaceutical company focused on developing proprietary, innovative, and differentiated therapies for the treatment of immuno-inflammatory conditions, today announced positive preclinical data in an ex vivo skin model of vitiligo.

March 7, 2022
·
8 min read
Drug Development

Optinose Reports Positive Top-line Results in ReOpen1, a Landmark Phase 3 Trial for XHANCE in Chronic Sinusitis

Optinose today announced that the ReOpen1 clinical trial met both of its co-primary endpoints.

March 7, 2022
·
9 min read
Business

Instil Bio Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update

Instil Bio, Inc. today reported its fourth quarter and year end 2021 financial results and provided a corporate update.

March 7, 2022
·
8 min read
Business

Turn Bio adds veteran executives with decades of international business development, intellectual property expertise

Hires will help to expand Turn’s commercial reach, protect its unique ERA Platform technology.

March 7, 2022
·
3 min read
Genetown

Servier Announces FDA Filing Acceptance and Priority Review for TIBSOVO® (ivosidenib tablets) in Combination with Azacitidine for Patients with Previously Untreated IDH1-mutated Acute Myeloid Leukemia

Servier today announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s supplemental New Drug Application (sNDA) for TIBSOVO.

March 7, 2022
·
16 min read
Business

Lyra Therapeutics Appoints Jim Tobin to Board of Directors

Lyra Therapeutics, Inc. today announced the appointment of Jim Tobin to its Board of Directors (BOD).

March 7, 2022
·
6 min read
Business

Nectin Therapeutics Announces $5.4 Million Investment from Cancer Focus Fund to Support Phase 1 Study of First-in-Class Anti-PVR Targeted Immunotherapy

Nectin Therapeutics Ltd. today announced a Cancer Focus Fund investment of $5.4 million to finance a Phase 1 clinical trial of Nectin’s PVR blocker, NTX1088, in cancer patients with locally advanced and metastatic solid tumors.

March 7, 2022
·
6 min read
Business

Ionis calls for applications for Janice Wiesman Young Investigator Grant Program

Ionis Pharmaceuticals, Inc. announced it is now accepting applications for the Janice Wiesman Young Investigator Grant Program, which honors Janice Wiesman, M.D., a leading global expert on the neurological impact of amyloidosis.

March 7, 2022
·
2 min read